Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. It develops novel, oral pharmaceutical treatment for mild-to-moderate psoriasis. It also supplies nutraceutical ingredients and finished products for dietary supplements. The company was founded by Hogne Hallaraker, Harald Nordal, and Jan Brevig Remmerelt in 2011 and is headquartered in Orsta, Norway.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company